{"id":"W4410816990","doi":"10.1200/jco.2025.43.16_suppl.tps4627","title":"Intravesical sacituzumab tirumotecan in participants with intermediate-risk non–muscle-invasive bladder cancer: The phase 1/2 TroFuse-027 study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Urothelial cancer; Cancer; Oncology; Urology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00182267,0.001161474,0.001435774,0.0002813066,0.0003365077,0.0006512685,0.0006860109,0.001376398,0.002494081],"category_scores_gemma":[0.0007991783,0.0004902114,0.001440612,0.0003297947,0.0005107192,0.0005741803,0.0003668502,0.001863276,0.0006595671],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000650002,"about_ca_system_score_gemma":0.00126937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001519353,"about_ca_topic_score_gemma":0.00353633,"domain_scores_codex":[0.9995765,0.0001953262,0.0000191846,0.00007189551,0.00004249322,0.00009457419],"domain_scores_gemma":[0.9994794,0.00005812922,0.0001089372,0.00003057742,0.0000455747,0.0002774388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7859205,0.03169264,0.04597647,0.002082406,0.004988556,0.0005005655,0.0003945271,0.000893125,0.02831598,0.0003392255,0.009414416,0.0894815],"study_design_scores_gemma":[0.5329448,0.3724062,0.07773826,0.0002039128,0.003879193,0.0006428142,0.0001757892,0.001161208,0.002410757,0.0003620428,0.008009467,0.00006551032],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858677,0.007314226,0.000510005,0.0005161767,0.0001482666,0.002357218,0.001882309,0.0000809523,0.001323038],"genre_scores_gemma":[0.9890385,0.002725472,0.000883231,0.0009902942,0.0001737809,0.002109329,0.002381529,0.00002160138,0.001676316],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002494081,"threshold_uncertainty_score":0.009639263,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09020439217103945,"score_gpt":0.4854147767435448,"score_spread":0.3952103845725053,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}